Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of KW-3902IV compared to placebo and to
determine the diuretic effect of KW-3902IV compared to placebo in patients hospitalized with
volume overload due to CHF who are refractory to high dose diuretic therapy.